The volume expansion associated to obesity strongly suggests that increased renal sodium reabsorption in the proximal tubule is an important factor that induces hypertension in obesity. 1 An important role in the regulation of sodium balance is played by nitric oxide (NO). 2-4 A series of in vivo and in vitro studies revealed a significant role of NO in the physiology and pathophysiology of the proximal tubule that is quantitatively the most important nephron site for sodium and water reabsorption. 5 NO affects renal sodium handling in virtually all nephron segments with effects on the salt and water reabsorption, 2,4 hemodynamics, 3 and tubuloglomerular feedback. 6 The general accepted notion is that NO exerts a tonic inhibitory effect on proximal tubular transport. Data indicate that both the basolateral and apical proximal tubule sodium transporters are changing in response to variations in NO. 7, 8 The apical sodium transporter NHE3 accounts for the majority of the luminal sodium absorption. 9 Cell culture studies in primary proximal tubule cells showed that NO donors reduce the activity of Na + /H + exchangers. 10 Also, in vivo chronic N G -nitro-l-arginine-methyl ester (l-NAME) treatment significantly increased expression of NHE3 in SpragueDawley rats 11 or in cirrhotic rats exhibiting sodium and water retention. 12 Nevertheless, in hyperaldosteronism NO positively modulates the expression of NHE3 contributing to the mechanism of aldosterone escape phenomenon. 13 Also, studies in proximal tubule cell lines indicated that NO depletion induces an increase in Na + , K + -ATPase molecular activity or protein expression. 7, 8 In obesity, renal nitric oxide production and/or bioavailability was reportedly reduced. 14,15 Our group found a decrease in urinary NO metabolites and increased expression of both endothelial NO synthase and neuronal NO synthase in the renal cortex and medulla in obese hypertensive rats compared to lean normotensive suggesting reduced systemic NO bioavailability, possibly due to increased oxidative stress. 16, 17 Interestingly, a recent finding in juvenile obese humans showed negative correlation between body mass index and NO metabolites and positive correlation between arginine and body mass index, suggesting increased NO production yet 
The volume expansion associated to obesity strongly suggests that increased renal sodium reabsorption in the proximal tubule is an important factor that induces hypertension in obesity. 1 An important role in the regulation of sodium balance is played by nitric oxide (NO). [2] [3] [4] A series of in vivo and in vitro studies revealed a significant role of NO in the physiology and pathophysiology of the proximal tubule that is quantitatively the most important nephron site for sodium and water reabsorption. 5 NO affects renal sodium handling in virtually all nephron segments with effects on the salt and water reabsorption, 2, 4 hemodynamics, 3 and tubuloglomerular feedback. 6 The general accepted notion is that NO exerts a tonic inhibitory effect on proximal tubular transport. Data indicate that both the basolateral and apical proximal tubule sodium transporters are changing in response to variations in NO. 7, 8 The apical sodium transporter NHE3 accounts for the majority of the luminal sodium absorption. 9 Cell culture studies in primary proximal tubule cells showed that NO donors reduce the activity of Na + /H + exchangers. 10 Also, in vivo chronic N G -nitro-l-arginine-methyl ester (l-NAME) treatment significantly increased expression of NHE3 in SpragueDawley rats 11 or in cirrhotic rats exhibiting sodium and water retention. 12 Nevertheless, in hyperaldosteronism NO positively modulates the expression of NHE3 contributing to the mechanism of aldosterone escape phenomenon. 13 Also, studies in proximal tubule cell lines indicated that NO depletion induces an increase in Na + , K + -ATPase molecular activity or protein expression. 7, 8 In obesity, renal nitric oxide production and/or bioavailability was reportedly reduced. 14, 15 Our group found a decrease in urinary NO metabolites and increased expression of both endothelial NO synthase and neuronal NO synthase in the renal cortex and medulla in obese hypertensive rats compared to lean normotensive suggesting reduced systemic NO bioavailability, possibly due to increased oxidative stress. 16, 17 Interestingly, a recent finding in juvenile obese humans showed negative correlation between body mass index and NO metabolites and positive correlation between arginine and body mass index, suggesting increased NO production yet original contributions Nitric Oxide and Sodium Transport in Obese and Lean Rats reduced NO bioavailability. 18 The integrated effect of NO on proximal tubular reabsorption may vary with the phenotype and the pathophysiological state. To the best of our knowledge, there are no reports on the effect of NO modulation on tubular sodium transport in diet-induced obesity and hypertension. The purpose of this study was to determine the specific effects of in vivo chronic NO inhibition in obese hypertensive and lean normotensive rats on high-fat diet on the pressure natriuresis and diuresis as well as effects on tubular sodium transporters. Since the proximal tubule sodium reabsorption is regulated by the rate-limiting apical entry step, 9 we focused on regulation of the major apical exchanger NHE3. We found that obese rats respond by a reduced change in natriuresis in response to NO inhibition compared to lean rats and the effect is associated to differences in regulation of NHE3 in the proximal renal tubule.
Methods

Animals and treatments.
All procedures involving animals were approved by the Institutional Animal Care and Use Committee of Eastern Virginia Medical School. Male 3-monthold Sprague-Dawley rats (Charles River, Wilmington, MA), were fed a moderately high-fat diet (~32% kcal as fat; Research Diets, New Brunswick, NJ) for 12 weeks. After 8 weeks, rats were assigned based on the differences in the body weight gains to obesity-prone (OP) and obesity-resistant (OR) groups, as described previously. 19 Half of the rats in each group (n = 6) were randomly selected and treated for 4 additional weeks with 1.2 mg/kg/day l-NAME in drinking water. This dose of l-NAME was reported to not significantly increase mean arterial pressure (MAP). 20 Body weight, food, and water intake were measured weekly. The effect of l-NAME on the pressure natriuresis and the expression and activity of NHE3 were determined in two separate sets of animals with identical dietary and treatment protocols.
Surgical procedure for acute pressure natriuresis experiments. The surgical procedure was performed as previously described 21 (see Supplementary Methods online).
Physiological parameters. MAP was measured in the anesthetized rats over 30 min, as described in Supplementary Methods online. The average trace was reported for the low (physiologic) perfusion pressure collection period. Glomerular filtration rate (GFR) was calculated in anesthetized rats from the clearance of inulin, and inulin concentration was measured by the anthrone method. 22 Sodium concentration in urine was measured by flame photometry using an EasyLyte Na/K analyzer (Medica, Bedford, MA). Nitrate/nitrite was measured in 24-h urine collected in metabolic cages and analyzed using a colorimetric kit from Cayman Chemicals (Ann Arbor, MI).
Membrane preparation and Western blotting. Kidney cortex was used for preparation of brush border membrane vesicles (BBMV), according to Biber et al. 23 Protein concentration was determined using BCA assay kit (Pierce Chemical, Rockford, IL). Equal amounts of protein (10-20 μg/lane) were subjected to 7.5% sodium dodecyl sulfate polyacrylamide gel electrophoresis and electroblotted. Membranes were incubated with NHE3 antibody (1:500 dilution; Novus) and Villin (1:1,000 dilution; Sigma, St Louis, MO) or with anti-Na + ,K + ATPase antibody (1:10,000 dilution; Upstate, Lake Placid, NY). Villin served as a loading control for NHE3 and Ponceau red staining was used to verify equal loading for Na + , K + -ATPase. For detection, fluorescently labeled secondary antibodies were used (IRDye 680; Li-Cor Biosciences, Lincoln, NE). Blots were quantified using Odyssey Infrared Imaging System.
Measurement of NHE3 activity. Na/H exchanger activity was measured in BBMV from renal cortex labeled with BCECF-AM (Molecular Probes, Eugene, OR) and the activity was expressed as the rate of pH recovery in response to an extravesicular Na load over 60 s. The specificity of the reaction was tested in the presence of 100 μmol/l 5-(N-ethyl-N-isopropyl) amiloride and 500 μmol/l amiloride (also see Supplementary Methods online).
Immunohistochemistry. Formalin-fixed, paraffin-embedded kidney sections were simultaneously incubated overnight at 4 °C, with polyclonal NHE3 antibody (1:200 dilution; Chemicon International, Temecula, CA) and monoclonal villin antibody (1:50 dilution; Immunotech, Chicago, IL). Fluorophoreconjugated secondary antibodies-Alexa Fluor488 goat antirabbit for and AlexaFluor594 goat anti-mouse at 1:500 dilution (Molecular Probes, Eugene, OR) were used for detection. Images were visualized using a Zeiss LSM 510 laser scanning microscope (Carl Zeiss Microscopy, Germany).
Data collection and image analysis.
The image analysis was performed using MetaMorph software v. 6.3 (Molecular Devices, Downingtown, PA). The detailed protocol is described in the Supplementary Methods online.
Statistical analysis. Two-tailed unpaired Student's t-test was used for the comparisons between the pressure natriuresis curves. Two-tailed paired Student's t-test was used to compare measurements between the first and the second clearance period during the acute pressure natriuresis experiments. One-way analysis of variance (ANOVA) was used for all comparisons between obese and lean groups with and without treatment and two-way ANOVA was used to determine interactions between the phenotype and l-NAME treatment. The null hypothesis was rejected for a P value <0.05. After 12 weeks on moderately high-fat diet (31 kcal% fat), the OP rats were on average ~23% heavier than the OR rats for both l-NAME treated and control groups ( Table 1 and Figure 1a ). The gradual increase in body weight in this rat model is paralleled by an increase in systolic blood pressure. 19 Downloaded from https://academic.oup.com/ajh/article-abstract/24/8/943/2743076 by guest on 01 February 2019 original contributions
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MAP at the end of the experiment was significantly increased in the OP vs. OR group ( Table 1) . l-NAME treatment did not significantly change MAP in either of the groups (Figure 1b) . Importantly, the level of NO chronic inhibition was comparable between the OP and OR groups after 4 weeks of l-NAME treatment and significantly decreased compared to nontreated control groups (Figure 1c) .
acute natriuretic and diuretic responses in oP and or rats and effect of l-naMe
In accordance to our previous data, 16 there was no difference between 24-h sodium excretion in OP and OR rats before the treatment (2.93 ± 0.61 vs. 2.43 ± 0.3 μEq/24 h). This result is consistent with the view that the sodium balance has reached steady state in a chronic setting. However, in response to acute changes in the renal perfusion pressure (RPP) we determined differences in the magnitude of the natriuretic and diuretic responses between the OP and OR rats ( Table 1 ). The increase in urine flow rate (V) in response to an increase in RPP was statistically significant for the OR rats only (Figure 2a ). This indicates a blunted diuresis in the obese compared to lean rats. Similarly, the increase in U Na V as well as FE Na in response to an increase in RPP were statistically significant in the OR but not in the OP group (Figure 3a,b) . The blunted pressure natriuresis and diuresis in the OP rats may account for the increase in MAP ( Table 1) . l-NAME treated rats displayed a significant decrease in the urine flow rate at the high perfusion pressure in the OR group compared to nontreated control, while the difference was not significant in the OP rats (Figure 2a) . Similarly, natriuresis, measured as U Na V and FE Na was significantly reduced by the l-NAME treatment only in the OR group. (Figure 3a,b) . Moreover, natriuresis is impaired more severely in l-NAME OR rats compared to l-NAME OP rats which is reflected by a lack of statistical difference between the measurements at low and high perfusion pressures in the former, but not in the latter group (Figure 3a,b) . Basal GFR was not significantly different between OP and OR groups suggesting that the difference in sodium excretion between the OP and OR rats was not due to a difference in GFR (Figure 2b) . In ΔFE Na (%) 0.6 ± 0.3 1.2 ± 0.4
The "Δ" values represent the difference in the respective parameter at two different perfusion pressures (102 ± 1.8 mm Hg and 139.8 ± 5.9 mm Hg). The total visceral fat represents the sum of the retro-peritoneal and epididymal fat pads. Values are mean ± s.e.m. FE Na , fractional excretion of sodium; GFR, glomerular filtration rate; MAP, mean arterial pressure; U Na V, rate of urinary sodium excretion; V, urine flow rate. *Significance was determined using the two-tailed t-test and the null hypothesis was rejected for a P value <0.05. , and (c) urinary nitrite/nitrate (NOx) in OP and OR rats with or without N g -nitro-l-arginine-methyl ester (l-NaME) treatment. all measurements were performed at the end of the experiment. MaP was measured under anesthesia, as described in Methods. Data represent mean ± s.d. from n = 6 rats/group. One-way analysis of variance (aNOVa) was used for statistical analysis and the null hypothesis was rejected for a P value <0.05. supplementary table s1 online summarizes the results of two-way aNOVa performed to evaluate interaction between phenotype (OP, OR) and treatment (l-NaME).
original contributions Renal perfusion pressure (mm Hg) , in OP and OR rats with or without N g -nitro-l-arginine-methyl ester (l-NaME) treatment. Urine was collected for 30 min at each perfusion pressure. Results represent mean ± s.e.m. from 4 to 5 rats/group. *significant compared to l-NaME treated at a similar perfusion pressure; § significant compared to the low perfusion pressure. significance was determined using the paired or unpaired two-tailed t-test and the null hypothesis was rejected for a P value < 0.05. l-NaME OP, treated obesity-prone; l-NaME OR, treated obesity-resistant; OP, untreated obesity-prone; OR, untreated obesity-resistant. Renal perfusion pressure (mm Hg) Sodium excretion (µEQ/min) a Figure 3 | Effects of changes in renal perfusion pressure on rate of sodium excretion (U Na V) and fractural excretion of sodium. (a) Fractional excretion of sodium (FE Na ) and (b) glomerular filtration rate were determined at two renal perfusion pressure levels as described in Figure 2 . Results represent mean ± s.e.m. from 4 to 5 rats/group. *significant compared to N g -nitro-l-arginine-methyl ester (l-NaME) treated at a similar perfusion pressure; § significant compared to the low perfusion pressure. significance was determined using the paired or unpaired two-tailed t-test and the null hypothesis was rejected for a P value <0.05. l-NaME OP, treated obesity-prone; l-NaME OR, treated obesity-resistant; OP, untreated obesity-prone; OR, untreated obesity-resistant. addition, GFR did not significantly change in response to acute changes in the RPP, with or without l-NAME treatment indicating that the rats in both groups maintained renal autoregulatory function (Figure 2b) .
nhe3 protein expression, activity and localization in oP and or rats in response to no inhibition
To determine whether different natriuretic responses are reflected in different molecular regulation of the sodium transport, we examined in a separate experiment the expression, activity, and localization of the rate-limiting apical sodium transporter NHE3.
First, we examined by Western blot NHE3 protein expression in BBMV isolated from kidney cortex (Figure 4a) . The linearity of the Western blotting signal and the purity of the BBMV preparation are shown in Supplementary Figure S1a and Table S2 online. The NHE3 protein expression was significantly higher by ~38% in the OP compared to OR rats (Figure 4a) . l-NAME treatment increased protein expression in both OP and OR groups compared to nontreated controls by ~36% and ~42%, respectively (Figure 4a) .
Next, we measured NHE3 activity in freshly isolated BBMV as the rate of pH recovery in response to an external sodium load. The rate of pH change was significantly higher by ~38% in OP vs. OR rats (Figure 4b) . Also, NHE3 activity was not significantly changed in the OP rats treated with l-NAME compared to the nontreated controls. In OR rats treated with l-NAME, the rate of pH change increased by ~53% compared to nontreated controls (Figure 4b) . The average traces from the four groups of rats (n = 6/group) illustrating the pH change over a 60-s time interval are shown in Figure 4b (bottom graph). The selectivity for NHE3 isoform was tested in the presence of 100 μmol/l 5-(N-ethyl-N-isopropyl) amiloride and the specificity of the fluorescent signal for Na/H exchange activity was evaluated using 500 μmol/l amiloride, shown to inhibit all NHE isoforms (see Supplementary Figure 1c online). 33 Two-way ANOVA analyses indicated that the effect of NO reduction was phenotype dependent for NHE3 activity and independent for NHE3 expression (see Supplementary  Table S1 online).
It is well established that the activity of NHE3 is complexly regulated by both interactions with regulatory factors and trafficking of the transporter in the brush border membrane. To further determine NHE3 trafficking, we conducted colocalization studies using confocal fluorescence microscopy. Representative fluorescent micrographs for different treatment groups are illustrated in Figure 5a . A significantly higher percentage of NHE3 immunostaining is colocalized with villin in the OP compared to OR rats (21.5 ± 2.5 vs. 9.1 ± 2.1%) (Figure 5a,b) and was not changed following l-NAME treatment in OP rats. However, in OR rats, l-NAME treatment significantly increased by ~58% the colocalization of NHE3 (a) Expression of NHE3 in the brush border membrane vesicles from renal cortex of obese and lean rats, nontreated (Nt) or treated with N g -nitro-l-arginine-methyl ester (l-NaME). top: histogram illustrating semi-quantitative analysis of Western blots by using the Odyssey Infrared Imaging system. Results are expressed as the NHE3/villin signal ratio and represent the mean ± s.d. from n = 6 rats/group. Bottom: Western blots from n = 6 rats/group. an equal amount of protein (20 μg) was loaded in each lane. Villin, which is exclusively expressed in the brush border membrane, served as a loading control. significance was attained for a P value <0.05. (b) activity of NHE3 in brush border membrane vesicles (BBMV) from renal cortex of Nt or l-NaME treated obese (OP) and lean (OR) rats. top: average data representing the rate of pH change in response to an external sodium load. Results represent mean ± s.d. of n = 6 rats/group. the null hypothesis was rejected for a P value <0.05. Bottom: average traces from control and treatment groups representing the change in pH over 60 s in response to an extravesicular sodium load. Freshly isolated BBMV were loaded with BCECF-aM for 30 min in a buffer with no sodium, and subsequently mixed with a buffer containing 150 mmol/l NaCl. the fluorescence at 490 nm and 440 nm was recorded over the first 60 s. the change in pH was plotted against time and was fitted to a 2nd exponential. the rate of the first exponential corresponding to the rapid increase in pH was used to express the Na + /H + exchanger activity.
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and villin. Two-way ANOVA showed that NO inhibition had a significant phenotype-dependent effect (see Supplementary  Table S1 online). The change in localization may account for the increased NHE3 activity measured in the l-NAME treated OR compared to untreated controls.
In conclusion, we found that NO inhibition results in an increased NHE3 activity only in the lean rats, due to an elevation in protein expression and a change in the localization of the transporter.
na + , k + -atPase expression is increased following no inhibition in or rats
Na + , K + -ATPase is also an important determinant of cellular sodium transport in the proximal tubule epithelial cells. The protein expression of Na + , K + -ATPase measured by Western blot in renal cortical basolateral membrane enriched preparations was significantly increased by ~45% in the obese compared to lean rats on high-fat diet (Figure 6 ). l-NAME treatment did not change the abundance of the pump in the OP rats but significantly increased by ~25% the protein expression of the latter in the OR group when compared to nontreated controls (Figure 6 ). The linearity of the Western blot signal is shown in Supplementary Figure S1a online. Two-way ANOVA analysis showed a significant phenotype-dependent effect of l-NAME treatment (see Supplementary Table S1 online).
The concerted increase in the abundance of Na + , K + -ATPase and the activity of NHE3 in the lean, but not in the obese rats could both account for the impaired natriuretic response in the l-NAME treated lean rats.
discussion
In this study, we found that in Sprague-Dawley rats with dietary-induced obesity and hypertension pressure natriuresis and diuresis are attenuated compared to lean controls on highfat diet, suggesting increased sodium retention. Our data is in accordance with previous studies indicating a blunted pressure natriuresis in both dietary-induced and genetic obesity hypertension. 15, 24 However, the mechanisms leading to renal sodium retention in obesity are only partly understood and likely involve both vascular and direct tubular mechanisms. Numerous studies showed that NO is an important regulator of blood pressure via effects on the vasculature as well as on the renal tubular transport. We previously showed that obese hypertensive rats have reduced NO bioavailability compared to lean counterparts. 16 A recent report indicates that impaired vascular vasodilation in overweight and obese humans appears to be independent of nitric oxide. 25 Therefore, hypertension associated to low levels of NO in obesity is unlikely caused by a peripheral vascular effect. In addition, we showed that the GFR is not different between OP and OR rats, indicating that tubular Results are expressed as mean ± s.d. the null hypothesis was rejected for a P value <0.05. l-OP, N g -nitro-l-arginine-methyl ester (l-NaME) treated OP rats; l-OR, l-NaME treated OR rats; Nt, nontreated; OP, obesity-prone; OR, obesity-resistant. mechanisms rather than hemodynamic changes are responsible for impaired pressure natriuresis and diuresis in the obese animals. Based on this evidence, we focused on examining the direct tubular effects of NO deficiency as a possible major mechanism responsible for the development and maintenance of hypertension in our animal model. To avoid the confounding effect of a change in arterial pressure, we have used an l-NAME concentration that did not result in a blood pressure change while effectively inhibiting NO production. We showed that the magnitude of change in natriuresis and diuresis upon NO inhibition is significantly higher in the lean compared to obese rats suggesting that obese rats are desensitized to in vivo chronic NO inhibition compared to lean. In addition, both OP and OR rats had similar levels of urinary nitrate/nitrite following l-NAME treatment, suggesting that differences in signaling events rather than NO availability is causing differences in the natriuretic responses. Since the apical sodium transport in proximal tubule is the rate-limiting step in tubular reabsorption, we determined the effect of l-NAME on expression, activity, and trafficking of NHE3. We found a significant increase in the NHE3 protein expression in renal cortex BBMV preparations in both the OP and OR rats on high-fat diet. The result is in accordance with previous in vivo studies indicating an increase in NHE3 abundance upon chronic l-NAME treatment in Sprague-Dawley rats, 26 cirrhotic rats, 12 and in rabbits. 10 However, NHE3 activity was significantly increased following chronic NO inhibition only in the OR rats. Also, the degree of colocalization of NHE3 with villin is significantly increased in OR rats only compared to untreated controls, indicating a raise in the abundance of the transporter in the microvilli. It is well documented that NHE3 activity is determined by multiple factors involving trafficking of the transporter, interaction with regulatory factors or transporter's half-life. 27 Biemesderfer et al. showed that NHE3 exists in two major pools in the proximal tubule brush border membrane located in the microvilli and in the intervillus spaces. 28, 29 The microvillar NHE3 appears to be the active pool, while the transporter located in the microvillar clefts is associated to megalin and is less active or inactive. 30 Association with villin is indicative of the microvillar localization therefore suggesting a more active transporter. Therefore, it is conceivable to conclude that in OR rats the increase in activity is not solely due to an increase in total expression but also due to a specific increase in the abundance in the microvilli. Conversely, in OP rats there is no significant change in localization following NO inhibition which could in part account for the lack in activity change. In addition to trafficking, NHE3 phosphorylation was associated with reduced transporter activity. 27 Phosphorylation is mediated by a variety of signals including cyclic adenosine monophosphate, cyclic guanosine monophosphate, calcium, and multiple kinases. Interestingly, one mechanism described in the intestinal microvillar membrane involves an increase in cGMP and subsequent activation of cGKII that leads to a reduction in NHE3 activity upon phosphorylation. 27 Since the inhibitory action of NO on NHE3 activity was shown to occur via an increase in sGC and cGMP in proximal tubules of rats, 10, 31 this could be a mechanism that prevents the removal of tonic inhibition of NHE3 in the obese rats with in vivo chronic NO inhibition and deserves further investigation. Interestingly, in a recent paper Jebelovszki et al. showed that in Sprague-Dawley rats, in vitro treatment with l-NAME induces impaired coronary vasodilation in lean but not in dietary-induced obese animals 32 and this may be due to increased levels of cGMP in the arteries of obese compared to lean rats. Although we did not measure cGMP levels in the renal tubule, this might be a plausible explanation for the attenuated response to NO depletion in our obese model and future investigation is granted. We also show that Na + , K + -ATPase protein is increased in the cortical membrane fraction of lean, but not obese rats following l-NAME treatment. Studies in proximal tubule cells indicated that NO depletion induces an increase in Na + , K + -ATPase molecular activity or protein expression. 7, 8 Therefore, the increased ATPase abundance in lean rats may be due to a direct effect of NO reduction, could be secondary to the apical increase in sodium influx to maintain intracellular Na + and K + concentration and cell volume, or both.
In this paper, we show that chronic NO inhibition impairs natriuresis significantly in lean but not in obese hypertensive animals. Impaired natriuresis is likely to be due to increased Na reabsorption in the proximal tubule since both Na + , K + -ATPase abundance and NHE3 activity are increased in lean but not in obese rats. The potential molecular mechanisms leading to this differential regulation such as NHE3 phosphorylation or increased cGMP tubular concentration in OP animals is currently under investigation. Mechanistic understanding of hypertension in obesity as well as the effect of dietary fat in different phenotypes could lead to finding better molecular targets for blood pressure control in obesity.
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